Amgen Acquires Otezla for $13.4 Billion
socalTECH
AUGUST 26, 2019
billion net of anticipated future cash tax benefits. billion in sales in 2018. Amgen said it expects low double-digit sales growth for Otezla over the next five years. According to Amgen, the deal will help strengthen its inflammation portfolio, and will be worth approximately $11.2 Otezla had $1.6
Let's personalize your content